299 related articles for article (PubMed ID: 29253594)
1. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
Yousefi S; Abbassi-Daloii T; Sekhavati MH; Tahmoorespur M
Microb Pathog; 2018 Feb; 115():50-56. PubMed ID: 29253594
[TBL] [Abstract][Full Text] [Related]
2. Impact of heat shock protein 60KD in combination with outer membrane proteins on immune response against Brucella melitensis.
Abbassi-Daloii T; Yousefi S; Sekhavati MH; Tahmoorespur M
APMIS; 2018 Jan; 126(1):65-75. PubMed ID: 29154438
[TBL] [Abstract][Full Text] [Related]
3. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the immunogenicity and efficacy of a chimeric OMP25-OMP31 antigen in BALB/c mice.
Mohammadi Y
Vet Med Sci; 2021 Sep; 7(5):2008-2014. PubMed ID: 34057317
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948
[TBL] [Abstract][Full Text] [Related]
6. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
[TBL] [Abstract][Full Text] [Related]
7. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
[TBL] [Abstract][Full Text] [Related]
8. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
[TBL] [Abstract][Full Text] [Related]
9. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
10. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
Gupta S; Singh D; Gupta M; Bhatnagar R
Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
[TBL] [Abstract][Full Text] [Related]
11. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
Tadepalli G; Konduru B; Murali HS; Batra HV
Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2015 Oct; 33(42):5532-5538. PubMed ID: 26384448
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
[TBL] [Abstract][Full Text] [Related]
15. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544.
Goel D; Bhatnagar R
Mol Immunol; 2012 Jun; 51(2):159-68. PubMed ID: 22464098
[TBL] [Abstract][Full Text] [Related]
16. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
[TBL] [Abstract][Full Text] [Related]
17. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
[TBL] [Abstract][Full Text] [Related]
18. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
[TBL] [Abstract][Full Text] [Related]
20. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
